IFN-gamma and self-absorbed CD4+ T cells: a regulatory double negative.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

2 citing papers in PubMed.

1. MicroRNA-22 controls interferon alpha production and erythroid maturation in response to infectious stress in mice.Experimental hematology · 2017
   Article
2. Clearance of HIV type 1 envelope recombinant sendai virus depends on CD4+ T cells and interferon-gamma but not B cells, CD8+ T cells, or perforin.AIDS research and human retroviruses · 2010
   Article

Corrections and comments

• Comment on
  The immunity-related GTPase Irgm1 promotes the expansion of activated CD4+ T cell populations by preventing interferon-gamma-induced cell death.2008

Authors and funding

2 authors.

Funding

Abstract

PubMed holds no abstract for this paper.

Indexed as